Thursday, August 21, 2014 10:02:21 PM
In accordance with ASC 855 the Company’s management reviewed all material events through the date of this report. The
Company has continued the financing process and from July 01 to August 07 a further conversion of 103,608,456 Common
Stock has been issued from converting Convertible Loan Notes. On July 1, 2014, the Board of Directors of the Company
approved an increase in the authorized capital stock to 1,600,000,000 shares consisting of 1,500,000,000 shares of common
stock, par value $0.0001, and 100,000,000 shares of preferred stock, par value $0.0001.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM